A multigenic program mediating breast cancer metastasis to bone
- PMID: 12842083
- DOI: 10.1016/s1535-6108(03)00132-6
A multigenic program mediating breast cancer metastasis to bone
Abstract
We investigated the molecular basis for osteolytic bone metastasis by selecting human breast cancer cell line subpopulations with elevated metastatic activity and functionally validating genes that are overexpressed in these cells. These genes act cooperatively to cause osteolytic metastasis, and most of them encode secreted and cell surface proteins. Two of these genes, interleukin-11 and CTGF, encode osteolytic and angiogenic factors whose expression is further increased by the prometastatic cytokine TGF beta. Overexpression of this bone metastasis gene set is superimposed on a poor-prognosis gene expression signature already present in the parental breast cancer population, suggesting that metastasis requires a set of functions beyond those underlying the emergence of the primary tumor.
Comment in
-
Metastatic cells will take any help they can get.Cancer Cell. 2011 Dec 13;20(6):689-90. doi: 10.1016/j.ccr.2011.11.022. Cancer Cell. 2011. PMID: 22172715 Free PMC article.
Similar articles
-
Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.J Bone Miner Res. 2006 Jul;21(7):1045-59. doi: 10.1359/jbmr.060416. J Bone Miner Res. 2006. PMID: 16813525
-
Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.PLoS One. 2012;7(5):e37361. doi: 10.1371/journal.pone.0037361. Epub 2012 May 21. PLoS One. 2012. PMID: 22629385 Free PMC article.
-
Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway.Med Oncol. 2013;30(3):634. doi: 10.1007/s12032-013-0634-4. Epub 2013 Jun 28. Med Oncol. 2013. PMID: 23813018
-
Parathyroid hormone-related protein and bone metastases.Cancer. 1997 Oct 15;80(8 Suppl):1572-80. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1572::aid-cncr7>3.3.co;2-d. Cancer. 1997. PMID: 9362424 Review.
-
Transforming growth factor-beta in osteolytic breast cancer bone metastases.Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S32-8. doi: 10.1097/01.blo.0000093055.96273.69. Clin Orthop Relat Res. 2003. PMID: 14600590 Review.
Cited by
-
Adhesion receptors as therapeutic targets for circulating tumor cells.Front Oncol. 2012 Jul 24;2:79. doi: 10.3389/fonc.2012.00079. eCollection 2012. Front Oncol. 2012. PMID: 22837985 Free PMC article.
-
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.Nature. 2015 Jun 4;522(7554):106-110. doi: 10.1038/nature14492. Epub 2015 May 27. Nature. 2015. Retraction in: Nature. 2023 May;617(7959):208. doi: 10.1038/s41586-023-06048-x PMID: 26017313 Free PMC article. Retracted.
-
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population.Hered Cancer Clin Pract. 2020 Jul 31;18:16. doi: 10.1186/s13053-020-00147-w. eCollection 2020. Hered Cancer Clin Pract. 2020. PMID: 32765800 Free PMC article.
-
Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer.Cancer Manag Res. 2022 Aug 23;14:2519-2531. doi: 10.2147/CMAR.S369910. eCollection 2022. Cancer Manag Res. 2022. PMID: 36039341 Free PMC article.
-
Unexpected Differences in the Speed of Non-Malignant versus Malignant Cell Migration Reveal Differential Basal Intracellular ATP Levels.Cancers (Basel). 2023 Nov 22;15(23):5519. doi: 10.3390/cancers15235519. Cancers (Basel). 2023. PMID: 38067222 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous